Abstract
A series of diphenhydramine analogues have been studied with regard to their formation of a metabolic intermediate (MI) during their biotransformation in phenobarbital induced rat hepatic microsomes. The MI forms a complex with reduced cytochrome P-450. MI complexation of cytochrome P-450 may result in drug-drug interactions and/or in cumulation of the parent compound. The extent of MI complex formation could be correlated with the lipophilicity of the substrates in a parabolic manner. A hydrophobic pocket of limited dimensions in cytochrome P-450 for the N-alkyl substituent of the substrates can be assumed. Moreover our data indicate a role for the O-atom in the diphenhydramine analogues for the interaction with cytochrome P-450.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
M. R. Franklin,Inhibition of mixed-function oxidations by substrates forming reduced cytochrome P-450 metabolic-intermediate complexes. Pharmacol. Ther. Part A3, 227–245 (1977).
A. Bast, E. M. Savenije-Chapel and J. Noordhoek,Relationship between molecular structure and cytochrome P-450-metabolic intermediate complex formation. J. Pharm. Sci.73, 953–956 (1984).
U. B. Paulsen-Sörman, K.-H. Jönssen and B. G. A. Lindeke,Cytochrome P-455 nm complex formation in the metabolism of phenylalkylamines 8. Stereoselectivity in metabolic intermediary complex formation with a series of chiral 2-substituted 1-phenyl-2-aminoethanes. J. Med. Chem.27, 342–346 (1984).
A. Bast and J. Noordhoek,Spectral interactions of orphenadrine and its metabolites with oxidized and reduced hepatic microsomal cytochrome P-450 in the rat. Biochem. Pharmacol.31, 2745–2753 (1982).
A. Bast, E. M. Savenije-Chapel, F. A. A. van Kemenade, L. W. C. Scheefhals and J. Noordhoek,Effect of multiple administration of orphenadrine or mono-N-desmethylorphenadrine on cytochrome P-450 catalyzed reactions in the rat. Arch. Toxicol.54, 131–137 (1983).
M. Hirata, B. Lindeke and S. Orrenius,Cytochrome P-450 product complexes and glutathione consumption produced in isolated hepatocytes by norbenzphetamine and its N-oxidized congeners. Biochem. Pharmacol.28, 479–484 (1979).
D. Larrey, M. Tinel, P. Letteron, J. Geneve, V. Descatoire and D. Pessayre,Formation of an inactive cytochrome P-450Fe(II)-metabolite complex after administration of amiodarone in rats, mice and hamsters. Biochem. Pharmacol.35, 2213–2220 (1986).
A. Bast, F. A. A. van Kemenade, E. M. Savenije-Chapel and J. Noordhoek,Product inhibition in orphenadrine metabolism as a result of a stable cytochrome P-450-metabolic intermediate complex formed during the disposition of mono-N-desmethylorphenadrine (tofenacine) in the rat. Res. Commun. Chem. Pathol. Pharmacol.40, 391–403 (1983).
R. F. Rekker and H. M. de Kort,The hydrophobic fragmental constant; an extension to a 1000 data point set. Eur. J. Med. Chem.14, 479–488 (1979).
L. K. Pershing and M. R. Frankling,Cytochrome P-450 metabolic-intermediate complex formation and induction by macrolide antibiotics; a new class of agents. Xenobiotica12, 687–699 (1982).
M. R. Franklin, C. R. Wolf, C. Serabjit-Singh, R. M. Philpot,Quantitation of two forms of pulmonary cytochrome P-450 in microsomes, using substrate specificities. Mol. Pharmacol.17, 415–420 (1980).
C. Hansch,quantitative relationships between lipophilic character and drug metabolism. Drug Metab. Rev.1, 1–13 (1972).
D. Larrey, M. Tinel and D. Pessayre,Formation of inactive cytochrome P-450Fe(II) metabolic complexes with several erythromycin derivatives but not with josamycin and midecamycin in rats. Biochem. Pharmacol.32, 1487–1493 (1983).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Bast, A., Valk, A.J. & Timmerman, H. Cytochrome P-450 metabolic-intermediate complex formation with a series of diphenhydramine analogues. Agents and Actions 30, 161–165 (1990). https://doi.org/10.1007/BF01969027
Issue Date:
DOI: https://doi.org/10.1007/BF01969027